Biotech Buyside

Does anyone have a sense for how beneficial a masters in biotech might be for a buyside role focusing on biotech? I'm looking to transition from consumer/tech hedge fund role to more biotech/healthcare focused and thinking about going back to school to improve my science background. Any thoughts?

Hedge Fund Interview Course

  • 814 questions across 165 hedge funds. Crowdsourced from over 500,000 members.
  • 11 Detailed Sample Pitches and 10+ hours of video.
  • Trusted by over 1,000 aspiring hedge fund professionals just like you.

Comments (2)

Most Helpful
  • Analyst 1 in IB-M&A
Apr 9, 2021 - 2:55am

One thing I have noticed at "top" biotech-focused funds is that the folks on the investment/research team will be highly educated and pedigreed --> MD's, PhD's, PharmD's Master's in Biotechnology etc...  In fact, if you do a quick linkedin search and some networking at these funds, many people will tell you that in order to be taken seriously they will at minimum want to see either some industry experience working at a large pharma company and/or solid science background with a minimum of Master's or higher (some publications would be nice). That being said I am sure at some smaller shops that "rule" may be more flexible and there might not be a need for more schooling.  

Start Discussion

Total Avg Compensation

June 2021 Hedge Fund

  • Vice President (18) $520
  • Director/MD (10) $359
  • NA (4) $325
  • Portfolio Manager (7) $297
  • Manager (4) $282
  • 3rd+ Year Associate (18) $269
  • 2nd Year Associate (26) $251
  • Engineer/Quant (51) $237
  • 1st Year Associate (63) $188
  • Analysts (183) $168
  • Intern/Summer Associate (15) $125
  • Junior Trader (5) $102
  • Intern/Summer Analyst (205) $82